A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients

BACKGROUND: Only a few prospective trials exist regarding the use of novel direct-acting antiviral agents (DAAs) in kidney transplant recipients (KTR) with chronic hepatitis C virus (HCV) infection. METHODS: This prospective single-center trial evaluated treatment with daclatasvir (DCV) and sofosbuv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Nephrol
Main Authors: Duerr, Michael, Schrezenmeier, Eva V., Lehner, Lukas J., Bergfeld, Léon, Glander, Petra, Marticorena Garcia, Stephan R., Althoff, Christian E., Sack, Ingolf, Brakemeier, Susanne, Eckardt, Kai-Uwe, Budde, Klemens, Halleck, Fabian
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360788/
https://ncbi.nlm.nih.gov/pubmed/30717681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1218-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker